Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - theophylline, quantity: 200 mg - tablet, modified release - excipient ingredients: guar gum; magnesium stearate; purified water - for the relief and prophylaxis of reversible bronchospasm associated with bronchial asthma, bronchitis, emphysema and related conditions.

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - glyceryl trinitrate, quantity: 54 mg - drug delivery system, transdermal - excipient ingredients: ethyl oleate; glyceryl laurate; acrylates/acrylamide copolymer - prevention of chronic stable angina pectoris due to coronary artery disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - glyceryl trinitrate, quantity: 36 mg - drug delivery system, transdermal - excipient ingredients: ethyl oleate; glyceryl laurate; acrylates/acrylamide copolymer - prevention of chronic stable angina pectoris due to coronary artery disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - glyceryl trinitrate, quantity: 18 mg - drug delivery system, transdermal - excipient ingredients: ethyl oleate; glyceryl laurate; acrylates/acrylamide copolymer - prevention of chronic stable angina pectoris due to coronary artery disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - theophylline, quantity: 250 mg - tablet, modified release - excipient ingredients: guar gum; magnesium stearate; purified water - for the relief and prophylaxis of reversible bronchospasm associated with bronchial asthma, bronchitis, emphysema and related conditions.

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - metronidazole, quantity: 7.5 mg/g - gel - excipient ingredients: carbomer 974p; propylene glycol; sodium hydroxide; disodium edetate; propyl hydroxybenzoate; methyl hydroxybenzoate; purified water - zidoval vaginal gel 0.75% is indicated in the treatment of symptomatic bacterial vaginosis (formerly referred to as haemophilus vaginalis vaginitis, gardnerella vaginalis vaginitis, non-specific vaginitis, corynebacterium vaginale vaginitis or anaerobic vaginosis). note: for purpose of this indicated, a clincial diagnosis of bacterial vaginosis is usually defined by the presence of at least three of the following four criteria: a) vaginal discharge ph of greater than 4.5, b) a vaginal discharge emitting a "fishy" amine odour when mixed with a 10% koh solution, c) a vaginal discharge containing clue cells on wet mount microscopy examination, d) a gram stain consistent with a diagnosis of bacterial vaginosis (lactobacillus morphotype absent of markedly decreased, gardnerella morphotype predominant flora, white blood cells absent or few, mobiluncus morphotype may or may not be present). a diagnosis of bacterial vaginosis requires that other pathogens which may be associated with genital infection, such as trichomonas vaginalis, candida albicans, chlamydia trachomatis and neisseria gonorrhoeae, should be ruled out be appropriate laboratory means.

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - diphenoxylate hydrochloride, quantity: 2.5 mg; atropine sulfate monohydrate, quantity: 25 microgram - tablet, uncoated - excipient ingredients: sorbitol solution (70 per cent) (non-crystallising); purified talc; light liquid paraffin; magnesium stearate; acacia; sucrose - lomitol is indicated as an adjunctive therapy for acute and chronic diarrhoea.tga approved 13 february 1985 date of last amendment 7 august 2007

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - orphenadrine citrate, quantity: 100 mg - tablet, modified release - excipient ingredients: ethylcellulose; lactose monohydrate; magnesium stearate; colloidal anhydrous silica - relief of painful muscle spasm associated with fibrositis, whiplash injuries, torticollis, prolapsed intervertebral disc, strains, sprains and similar conditions. has also been shown to be of value in tension headache and persistent hiccup.

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - beclometasone dipropionate, quantity: 0.1 mg/actuation - inhalation, pressurised - excipient ingredients: ethanol; norflurane - qvar is indicated for the prophylactic management of asthma.

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - beclometasone dipropionate, quantity: 0.1 mg/actuation - inhalation, pressurised - excipient ingredients: ethanol; norflurane - prophylactic management of asthma.